That's great, - for the doctors and the patients. I would prefer PAR is making these discoveries. I haven't looked at patents law closely, but if we have a patent for iPPS for conditions A, B & C, would we be vulnerable if it also worked for conditions D, E, & F which we don't have a patent for yet? Could someone then run with the same drug or a variation of, for other conditions which our drug has proven successful with, because we don't have that patent?
That's great, - for the doctors and the patients. I would prefer...
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.015(6.67%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 24.0¢ | 22.5¢ | $173.6K | 743.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 99346 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 131244 | 5 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |